Upstream Bio (UPB) Consolidated Net Income (2023 - 2025)
Historic Consolidated Net Income for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to -$33.7 million.
- Upstream Bio's Consolidated Net Income fell 11095.13% to -$33.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.2 million, marking a year-over-year decrease of 11352.39%. This contributed to the annual value of -$65.6 million for FY2024, which is 8259.48% down from last year.
- According to the latest figures from Q3 2025, Upstream Bio's Consolidated Net Income is -$33.7 million, which was down 11095.13% from -$39.9 million recorded in Q2 2025.
- In the past 5 years, Upstream Bio's Consolidated Net Income registered a high of -$7.9 million during Q3 2023, and its lowest value of -$39.9 million during Q2 2025.
- Moreover, its 3-year median value for Consolidated Net Income was -$16.0 million (2024), whereas its average is -$20.8 million.
- As far as peak fluctuations go, Upstream Bio's Consolidated Net Income plummeted by 6581.06% in 2024, and later crashed by 17222.26% in 2025.
- Over the past 3 years, Upstream Bio's Consolidated Net Income (Quarter) stood at -$12.8 million in 2023, then crashed by 65.81% to -$21.2 million in 2024, then plummeted by 58.78% to -$33.7 million in 2025.
- Its Consolidated Net Income stands at -$33.7 million for Q3 2025, versus -$39.9 million for Q2 2025 and -$27.3 million for Q1 2025.